Our Pricing

What Is the Average Weight Loss with Mounjaro? UK Clinical Data & Real Results

Published: 10 September 2026

Understanding mounjaro average weight loss is essential for anyone considering this tirzepatide injection for weight management in the UK. Clinical trials demonstrate that patients using Mounjaro achieve an average weight loss of 15% to 22.5% of their body weight over 72 weeks, depending on the dose prescribed[1]. At Cured Pharmacy, we provide Mounjaro from £124.99 following a free online consultation with our UK-registered prescribers, ensuring you receive evidence-based guidance tailored to your weight loss goals.

Mounjaro Average Weight Loss: What Clinical Trials Show

The mounjaro average weight loss data comes primarily from the SURMOUNT-1 trial, which enrolled over 2,500 adults with obesity or overweight conditions[1]. Participants receiving the 5mg dose lost an average of 15% of their body weight, whilst those on the 10mg dose achieved 19.5% weight loss, and the highest 15mg dose resulted in 22.5% average weight loss over 72 weeks[1]. These results represent some of the most significant weight reductions ever documented in obesity medication trials.

To contextualise these figures, a person weighing 100kg (15st 10lb) on the 10mg dose could expect to lose approximately 19.5kg (3st 1lb) on average over the 72-week treatment period[1]. Individual results vary based on adherence to lifestyle modifications, starting BMI, metabolic factors, and dose titration schedule. Our clinical team at Cured Pharmacy works with each patient to optimise dosing and support sustainable weight loss outcomes.

How Mounjaro Average Weight Loss Compares to Other Treatments

When evaluating mounjaro average weight loss against other GLP-1 receptor agonists, tirzepatide demonstrates superior efficacy. Semaglutide (Wegovy) produces an average weight loss of 15% over 68 weeks in the STEP trials[2], whilst liraglutide (Saxenda) achieves approximately 8% average weight loss[3]. Mounjaro's dual GIP/GLP-1 receptor agonist mechanism contributes to its enhanced weight reduction profile, making it the most effective pharmacological option currently available in the UK for chronic weight management[1].

Timeline for Mounjaro Average Weight Loss Results

The mounjaro average weight loss timeline follows a gradual, progressive pattern that aligns with the dose escalation schedule. Most patients begin noticing weight reduction within the first 4 weeks of treatment, with average losses of 2-3% body weight during the initial 2.5mg dose phase[1]. By week 20, when many patients reach maintenance doses of 10mg or 15mg, average cumulative weight loss typically ranges from 10-12% of starting body weight[1].

Peak mounjaro average weight loss occurs around week 72, though many patients continue to see modest reductions beyond this point with sustained treatment[1]. The gradual nature of weight loss with Mounjaro is clinically advantageous, as it allows for metabolic adaptation and reduces the likelihood of rapid weight regain. Our pharmacists at Cured Pharmacy emphasise that consistency with weekly injections and adherence to dietary guidance are critical factors in achieving results that match or exceed clinical trial averages.

Factors That Influence Mounjaro Average Weight Loss in Individual Patients

Whilst clinical trials provide valuable mounjaro average weight loss benchmarks, individual outcomes depend on multiple variables. Starting BMI significantly impacts absolute weight loss: patients with higher baseline BMIs often lose more total kilograms, though percentage reductions remain relatively consistent across BMI categories[1]. Metabolic factors including insulin resistance, thyroid function, and medication history also influence response rates.

Lifestyle adherence is perhaps the most modifiable factor affecting mounjaro average weight loss outcomes. Patients who combine tirzepatide treatment with a reduced-calorie diet and regular physical activity consistently achieve results at or above trial averages[1]. Sleep quality, stress management, and medication timing also play supporting roles. Our clinical team provides comprehensive guidance on optimising these factors to maximise your individual weight loss trajectory with Mounjaro treatment.

Dose-Dependent Effects on Mounjaro Average Weight Loss

The relationship between dose and mounjaro average weight loss is clearly established in clinical data. The 5mg maintenance dose produces approximately 15% average weight loss, the 10mg dose achieves 19.5%, and the 15mg dose results in 22.5% average reduction[1]. However, higher doses also carry increased risk of gastrointestinal side effects, requiring careful clinical judgement when escalating treatment. Your prescriber will determine the optimal dose based on your tolerance, weight loss progress, and medical history during ongoing consultations.

Maintaining Mounjaro Average Weight Loss After Treatment

Sustaining mounjaro average weight loss beyond the active treatment phase requires strategic planning and ongoing support. Clinical data from extension studies indicate that patients who discontinue Mounjaro typically regain approximately one-third to one-half of their lost weight within 12 months[4]. This highlights the chronic nature of obesity and the importance of viewing tirzepatide as part of a long-term weight management strategy rather than a temporary intervention.

To maintain mounjaro average weight loss results, most patients benefit from continued treatment at a maintenance dose, combined with established dietary and exercise habits. Some individuals successfully transition to lower maintenance doses (such as 5mg) after achieving their target weight, whilst others require ongoing treatment at their effective dose to prevent regain[4]. Our clinical team at Cured Pharmacy provides regular follow-up consultations to monitor weight maintenance and adjust treatment plans as needed, ensuring sustainable outcomes that align with your long-term health goals.

Safety Considerations and Mounjaro Average Weight Loss Expectations

Understanding realistic mounjaro average weight loss expectations is crucial for treatment satisfaction and safety. Whilst clinical trials demonstrate impressive average results, approximately 10-15% of patients are classified as non-responders, achieving less than 5% weight loss despite optimal dosing[1]. Setting appropriate expectations during initial consultations helps patients remain committed to treatment even if their individual trajectory differs from published averages.

Common side effects that may impact mounjaro average weight loss include nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation phases[1]. These gastrointestinal symptoms typically diminish over 4-8 weeks as tolerance develops. Severe or persistent side effects may necessitate dose reduction or treatment discontinuation, potentially affecting overall weight loss outcomes. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures that all patients receive comprehensive safety monitoring and side effect management guidance throughout their Mounjaro treatment journey.

Who Achieves Above-Average Weight Loss with Mounjaro

Certain patient populations consistently exceed mounjaro average weight loss benchmarks in clinical practice. Individuals who are treatment-naïve to GLP-1 medications, maintain excellent adherence to injection schedules, implement significant dietary changes, and engage in regular physical activity often achieve weight reductions of 25-30% or more[1]. Younger patients and those without significant metabolic comorbidities also tend to respond more robustly to tirzepatide treatment. However, even patients with complex medical histories can achieve clinically meaningful weight loss with appropriate clinical support and realistic goal-setting.

Accessing Mounjaro for Weight Loss at Cured Pharmacy

At Cured Pharmacy, we make accessing Mounjaro straightforward whilst maintaining the highest clinical standards. After completing a free online consultation that takes under 3 minutes, our UK-registered prescribers review your medical history, current medications, weight loss goals, and suitability for tirzepatide treatment. If approved, your Mounjaro prescription is dispensed from our GPhC-registered pharmacy (9012511) and delivered in discreet packaging directly to your address.

We provide transparent upfront pricing with Mounjaro available from £124.99, and new patients receive £20 off their first order using code Weightlossnew. Unlike some providers, we show exact pricing before consultation, ensuring no unexpected costs. Our clinical team remains available throughout your treatment for dose adjustments, side effect management, and ongoing support to help you achieve mounjaro average weight loss results or better. All medications are genuine UK-licensed products, and every prescription requires approval from a qualified UK prescriber in accordance with MHRA regulations.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 10 September 2026]
2. Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 10 September 2026]
3. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 10 September 2026]
4. Aronne, L. J., Sattar, N., Horn, D. B., et al. (2024). Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial. JAMA, 331(1), 38-48. [accessed 10 September 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 10 September 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 10 September 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 10 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.